New heart device under watch: belgian study monitors EV-ICD performance
NCT ID NCT07156851
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This observational study will follow 100 patients in Belgium who have received an extravascular implantable cardioverter-defibrillator (EV-ICD) as part of their routine care. Researchers will collect data from medical records on device performance, complications, and patient outcomes over the device's lifetime. No extra tests or visits are required for participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this registry will provide real-world data on how well the EV-ICD works and its safety, helping doctors improve care for patients needing defibrillators.
What could go wrong
This is an observational study, not a treatment trial. It only collects data, so it won't directly improve patient outcomes. Results depend on consistent follow-up over many years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••